Calvariae B in Mouse κ and Receptor Activator of NF - B Ligand , Osteoprotegerin , κ Activator of NF - Regulate the Expression of Receptor Oncostatin M Stimulate Bone Resorption and IL - 6 , Leukemia Inhibitory

IL-6, Leukemia Inhibitory Factor, and Oncostatin M Stimulate Bone Resorption and Regulate the Expression of Receptor Activator of NF- B Ligand, Osteoprotegerin, and Receptor Activator of NF- B in Mouse Calvariae

κ Activator of NF - Regulate the Expression of Receptor Oncostatin M Stimulate Bone Resorption

Combined Hydroxyapatite Scaffold and Stem Cell from Human Exfoliated Deciduous Teeth Modulating Alveolar Bone Regeneration via Regulating Receptor Activator of Nuclear Factor-Κb and Osteoprotegerin System

Background: Tissue engineering using Stem cell from Human Exfoliated Deciduous Teeth (SHED) and a natural biomaterials biomaterial scaffold has become a promising therapy for the alveolar bone defect. The aim of this study was to analyze the Osteoprotegerin (OPG) and Receptor Activator of NF-Κb ligand (RANKL) expression after the application of Hydroxyapatite scaffold and SHED.Methods: A labora...

Umeå University Odontological Dissertations

Osteotropic Cytokines: Expression in Human Gingival Fibroblasts and Effects on Bone. Py Palmqvist, Department of Oral Cell Biology, Umeå University, SE-901 87 Umeå, Sweden Bone metabolism is regulated by endocrine and paracrine signalling molecules influencing bone cells in the continuously remodelling bone tissue. These molecules include a variety of osteotropic stimulatory and inhibitory cyto...

Pathophysiology of RANK ligand (RANKL) and osteoprotegerin (OPG).

Receptor activator of nuclear factorκ B ligand (RANKL) is a membrane-bound peptide of the tumor necrosis factor (TNF) ligand superfamily [14]. Rich sources of RANKL expression include T lymphocytes [12] and osteoblastic lineage cells [8]. In the presence of permissive concentrations of macrophage-colony stimulating factor (M-CSF), RANKL stimulates the differentiation, proliferation, fusion and ...